Clinical trial Recruiting at 1 site Interventional Ages 7 to 11

Mindfulness-based emotion regulation training to help hospitalized children aged 7–11 manage fear

Official title: The Effect of Mindfulness-Based Emotion Regulation Training on Fear and Emotion Regulation in Hospitalized Children

Run by Ataturk University · NCT07379021 · Data updated 2026-11-12

This project will try a short mindfulness program to help hospitalized 7–11-year-old children manage their emotions and lower fear related to medical care.

Quick facts

Study typeInterventional
Ages7 Years to 11 Years
SexAll
Enrollment54 (estimated)
SponsorAtaturk University
Academic / other
Locations1 site (Erzurum)
StatusRecruiting
StartedDecember 26, 2025
Main results expectedDecember 26, 2026
Study endsDecember 26, 2027
Registry record updatedJanuary 30, 2026
Trial IDNCT07379021 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 7–11 who can read, write, speak and understand Turkish, have a planned hospital stay of at least four days, can communicate normally, and whose parent and child agree to participate.

Probably not a fit

Children with severe pain or acute respiratory distress, known psychiatric diagnoses, hearing/speech problems that prevent communication, or prior similar mindfulness training are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll hospitalized children aged 7–11 and randomly assign them to a mindfulness-based emotion regulation training or to routine nursing care. The intervention will be delivered during an expected hospital stay of at least four days, with measurements taken at admission and at follow-up using the Child and Parent Introduction Form, the Emotion Regulation Scale for Children and Adolescents, and the Medical Procedure Fear Scale. The program aims to teach sustainable emotion-regulation strategies rather than relying on brief distraction during procedures, targeting reduced fear and improved adaptive regulation. The trial is scheduled from April 2026 to April 2027 at Atatürk University Nursing Faculty in Erzurum, Turkey.

Why it matters

Potential benefit: If successful, the training could reduce children's hospital-related fear and strengthen long-term emotion-regulation skills, making medical care less distressing and improving treatment cooperation.

How similar studies have gone: Related mindfulness and emotion-regulation programs have shown benefits for pediatric anxiety in outpatient settings, but applying them specifically to hospitalized children's procedural fear is less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Be aged between 7 and 11 years old,
* Have a planned hospital stay of at least four days,
* Be able to speak and understand Turkish,
* Be able to read and write (to complete questionnaires),
* The child and parent must be willing to participate in the study.

Exclusion Criteria:

* The child has a hearing/speech problem that prevents them from communicating,
* The child has severe pain or acute respiratory distress that prevents them from participating,
* The child has a known psychiatric diagnosis,
* The child has previously received similar mindfulness training

Where it's running

  • Ataturk University Nursing of Faculty
    Erzurum, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.